Transgenic expression of osteoactivin in the liver attenuates hepatic fibrosis in rats
Authors:
- Hirohito TsubouchiHTHirohito Tsubouchi
- 1 May 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 356 (3) , 610-615
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Dominant-negative soluble PDGF-β receptor inhibits hepatic stellate cell activation and attenuates liver fibrosisLaboratory Investigation, 2004
- Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, l-amino acid-defined diet, accelerates motility of hepatoma cellsJournal of Hepatology, 2003
- Conditional Tetracycline–Regulated Expression of Tgf–β1 in Liver of Transgenic Mice Leads to Reversible Intermediary FibrosisHepatology, 2003
- Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblastsJournal of Cellular Biochemistry, 2001
- Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in ratsHepatology, 2001
- Molecular Cloning of a Dendritic Cell-associated Transmembrane Protein, DC-HIL, That Promotes RGD-dependent Adhesion of Endothelial Cells through Recognition of Heparan Sulfate ProteoglycansJournal of Biological Chemistry, 2001
- In vivo inhibition of rat stellate cell activation by soluble transforming growth factor β type II receptor: A potential new therapy for hepatic fibrosisProceedings of the National Academy of Sciences, 1999
- Long‐term administration of interferon‐α in non‐responder patients with chronic hepatitis C: follow‐up of liver fibrosis over 5 yearsJournal of Viral Hepatitis, 1999
- Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver.Proceedings of the National Academy of Sciences, 1994
- A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections.Journal of Histochemistry & Cytochemistry, 1985